U.S. literacy crisis keeps getting worse
What is established Evidence from the 2025 Programme for International Student Assessment (PISA) and the National Assessment of Educational Progress (NAEP) indicates a sustained decline in reading proficiency among U.S. students over the past decade. This decline started prior to the COVID-19 pandemic and affects both fourth and eighth graders. The trend…
UN Finds Age-Based Persecution of Palestinian Children
Human Rights Watch News: UN Finds Age-Based Persecution of Palestinian Children What is established On October 14, 2026, a United Nations Commission of Inquiry issued a report concluding that Israeli authorities have committed the crime against humanity of persecution against Palestinian children in the West Bank. The Commission emphasized that children there…
Mbappé, Mao, and La Liga
What is established In April 2026, Kylian Mbappé, a prominent football player for Real Madrid, made a comment comparing himself humorously to a “Chinese dictator” during an interview. The remark was picked up and amplified by a Chinese sports broadcaster who paired it with imagery of Mao Zedong, the founding leader of…
Women Should Never Give Birth in Shackles
Women Should Never Give Birth in Shackles: An Evidence Dossier What is established It is a recognized international human rights principle that prisoners, including incarcerated women, retain their fundamental rights to health, humane treatment, and dignity. Specifically, the United Nations Bangkok Rules prohibit the use of restraints on women during labor, childbirth,…
Amazon mining boss wanted by Brazil for sheltering Jair Bolsonaro’s spy chief has businesses, properties in Florida
What is established A Brazilian gold miner named Rodrigo Martins de Mello, also known as Rodrigo Cataratas, is wanted by Brazilian authorities. The Supreme Court of Brazil has ordered his arrest in connection with the alleged facilitation of the escape to Florida of Alexandre Ramagem, former director of Brazil’s intelligence agency during…
Pancreatic cancer: The RAS paradigm shift
Pancreatic Cancer: The RAS Paradigm Shift – An Evidence Dossier Source: PLOS Medicine, article published October 29, 2026, by Samuel P. Soff and Eileen M. O’Reilly What is Established Pancreatic ductal adenocarcinoma (PDAC) is recognized as one of the deadliest cancers, with a five-year survival rate near 13%. It often presents late…
Immunogenicity and safety of Institut Pasteur du Cambodge (IPC) and updated Thai Red Cross (UTRC) intradermal rabies vaccine regimens among healthy adults in India: A phase 4, open label, equivalence randomised controlled trial
Immunogenicity and Safety of Shorter Intradermal Rabies Vaccine Regimens in India: Evidence from a Phase 4 Trial Rabies remains a fatal viral disease with significant public health impact worldwide, especially in India, which bears a large proportion of the global burden. Post-exposure prophylaxis (PEP) through anti-rabies vaccination is critical for preventing rabies…
Bearing witness in war zones
Bearing Witness in War Zones: An Evidence Dossier What is established Ron Haviv is an award-winning filmmaker and photographer who has documented armed conflicts worldwide for over three decades. As a co-founder of the VII Foundation, Haviv supports and educates photojournalists aiming to use visual storytelling to inspire change. His career started…
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 77, Status: Authorised
Opdivo (Nivolumab) – European Public Assessment Report Evidence Dossier What is established Opdivo, whose active substance is nivolumab, is an immune checkpoint inhibitor authorized by the European Medicines Agency (EMA) for the treatment of several advanced cancers. Opdivo targets PD-1, a receptor on immune T cells, preventing cancer cells from switching off…
Human medicines European public assessment report (EPAR): Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron), dinutuximab beta, Date of authorisation: 08/05/2017, Revision: 19, Status: Authorised
Qarziba (Dinutuximab beta) for Neuroblastoma: An Evidence Dossier What is established Qarziba is a medicinal treatment authorised in the European Union for the management of neuroblastoma, a cancer of nerve cells primarily affecting children older than one year. It was granted marketing authorisation under exceptional circumstances by the European Medicines Agency (EMA)…